Literature DB >> 9014990

Deletion polymorphism of angiotensin-converting enzyme gene and left ventricular hypertrophy in southern Italian patients.

F Perticone1, R Ceravolo, C Cosco, M Trapasso, A Zingone, P Malatesta, N Perrotti, D Tramontano, P L Mattioli.   

Abstract

OBJECTIVES: This study sought to evaluate the possible association of polymorphism of the angiotensin-converting enzyme (ACE) gene with blood pressure and left ventricular mass index (LVMI).
BACKGROUND: The renin-angiotensin system seems to be involved in the pathogenesis of essential hypertension. Moreover, recent epidemiologic observations demonstrate that many subjects with left ventricular hypertrophy have normal blood pressure levels, suggesting that factors other than hemodynamic overload may contribute to the hypertrophy.
METHODS: The study included 140 untreated hypertensive outpatients who underwent ambulatory blood pressure monitoring, echocardiographic evaluation and analysis for insertion (I)/ deletion (D) polymorphism in intron 16 of the ACE gene by polymerase chain reaction. Blood pressure was measured at 24 h, and LVMI was calculated by the Devereux formula, in each patient.
RESULTS: Left ventricular mass index values (mean +/- SD) were 137 +/- 28 g/m2 in patients with the DD genotype, 125 +/- 27 g/m2 in those with the ID genotype and 115 +/- 27 g/m2 in those with II genotype. The frequencies of the DD, ID and II genotypes were 45.71% (n = 64), 46.42% (n = 65) and 7.85% (n = 11), respectively, and were in Hardy-Weinberg equilibrium. The strongest association between left ventricular mass and DD genotype in our cohort appeared to be an independent cardiovascular risk factor (DD vs. ID: odds ratio [OR] 2.497, 95% confidence interval [CI] interval 1.158 to 5.412, p < 0.05; DD vs. II: OR 6.577, 95% CI 1.169 to 28.580, p < 0.02).
CONCLUSIONS: Our data show that the LVMI was significantly enhanced in patients with the DD genotype.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9014990     DOI: 10.1016/s0735-1097(96)00485-8

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  10 in total

1.  Angiotensin-converting enzyme gene deletion allele increases the risk of left ventricular hypertrophy: evidence from a meta-analysis.

Authors:  Xiaobo Li; Yuqiong Li; Nan Jia; Shujie Guo; Shaoli Chu; Wenquan Niu
Journal:  Mol Biol Rep       Date:  2012-07-07       Impact factor: 2.316

2.  Association between ACE and AGT polymorphism and cardiovascular risk in acromegalic patients.

Authors:  Tomris Erbas; Nese Cinar; Selcuk Dagdelen; Arzu Gedik; Hikmet Yorgun; Ugur Canpolat; Giray Kabakci; Mehmet Alikasifoglu
Journal:  Pituitary       Date:  2017-10       Impact factor: 4.107

3.  Genetic Determinants of Dyslipidemia in African-Based Populations: A Systematic Review.

Authors:  Jean Jacques Noubiap; Edith Pascale M Mato; Magellan Guewo-Fokeng; Arnaud D Kaze; Houssam Boulenouar; Ambroise Wonkam
Journal:  OMICS       Date:  2018-12

Review 4.  Effect of interaction between left ventricular dysfunction and endothelial function in hypertension.

Authors:  Angela Sciacqua; Francesco Borrello; Marco Vatrano; Rosa Daniela Grembiale; Francesco Perticone
Journal:  Curr Hypertens Rep       Date:  2006-06       Impact factor: 5.369

5.  Early sign of atherosclerosis in slow coronary flow and relationship with angiotensin-converting enzyme I/D polymorphism.

Authors:  Halil Tanriverdi; Harun Evrengul; Hatice Mergen; Ceren Acar; Deniz Seleci; Omur Kuru; Seyhan Tanriverdi; Asuman Kaftan
Journal:  Heart Vessels       Date:  2007-01-26       Impact factor: 2.037

6.  The TRIB3 R84 variant is associated with increased left ventricular mass in a sample of 2426 White individuals.

Authors:  Gaia Chiara Mannino; Carolina Averta; Teresa Vanessa Fiorentino; Elena Succurro; Rosangela Spiga; Elettra Mancuso; Sofia Miceli; Maria Perticone; Angela Sciacqua; Francesco Andreozzi; Giorgio Sesti
Journal:  Cardiovasc Diabetol       Date:  2021-05-29       Impact factor: 9.951

7.  One-hour postload plasma glucose levels and left ventricular mass in hypertensive patients.

Authors:  Angela Sciacqua; Sofia Miceli; Giuseppe Carullo; Laura Greco; Elena Succurro; Franco Arturi; Giorgio Sesti; Francesco Perticone
Journal:  Diabetes Care       Date:  2011-04-22       Impact factor: 19.112

8.  Epistatic effects of ACE I/D and AGT gene variants on left ventricular mass in hypertensive patients: the HyperGEN study.

Authors:  A I Lynch; W Tang; G Shi; R B Devereux; J H Eckfeldt; D K Arnett
Journal:  J Hum Hypertens       Date:  2011-01-20       Impact factor: 3.012

9.  Association of ACE gene D polymorphism with left ventricular hypertrophy in patients with diastolic heart failure: a case-control study.

Authors:  Ehsan Bahramali; Mona Rajabi; Javad Jamshidi; Seyyed Mohammad Mousavi; Mehrdad Zarghami; Alireza Manafi; Negar Firouzabadi
Journal:  BMJ Open       Date:  2016-02-09       Impact factor: 2.692

10.  Angiotensin-converting enzyme insertion/deletion polymorphism, 24-h blood pressure profile and left ventricular hypertrophy in hypertensive individuals: a cross-sectional study.

Authors:  Luciana Neves Cosenso-Martin; Renan Oliveira Vaz-de-Melo; Luana Rocco Pereira; Cláudia Bernardi Cesarino; Juan Carlos Yugar-Toledo; José Paulo Cipullo; Marcela Augusta de Souza Pinhel; Dorotéia Rossi Silva Souza; José Fernando Vilela-Martin
Journal:  Eur J Med Res       Date:  2015-09-04       Impact factor: 2.175

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.